ReviewCancer biology & therapy2024

T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer.

Julia Palecki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.